Pamela J Shaw

Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

N. Krogan, M. Snyder, M. Collins, 2022, bioRxiv.

Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene

D. Lancet, M. Snyder, J. Landers, 2020, Cell reports.

Telomere length is greater in ALS than in controls: a whole genome sequencing study

Ashley R. Jones, S. Newhouse, J. Powell, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Lateral Sclerosis Degeneration Telomere length is greater in ALS than in controls: a whole genome sequencing study

Ahmad Al Khleifat, Ashley R. Jones, A. Iacoangeli, 2019 .

Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.

D. Lancet, M. Snyder, A. Al-Chalabi, 2021, Cell reports.

Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival

P. Heath, J. Kirby, Mbombe Kazoka, 2023, Brain communications.

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

Panteleimon G. Takis, Megan L. Nagel, S. Sawcer, 2023, Nature communications.

Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis

D. Arking, J. Veldink, S. Battle, 2024, Heliyon.

Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders

Ashley R. Jones, R. Marioni, A. McRae, 2021, Genome Biology.